Abstract
Purpose
The efficacy of screening mammography in reducing breast cancer mortality continues to be controversial. In addition, few data exist on the efficacy of screening mammography in women 70 years of age or older. An organized screening mammogram program has existed in Saskatchewan since the mid-1990s. It offers mammography every 2 years to women ≥50 years of age.
Methods
We conducted a population-based case–control study to evaluate the efficacy of screening mammography, as practiced in Saskatchewan, Canada. Cases (n = 501) were women who died of breast cancer during 1995–2008 and were at least 52 years of age at the time of their diagnosis. Controls (n = 5,009) were matched to cases on birth year and duration of healthcare coverage prior to the cases’ breast cancer diagnosis date. In cases and controls, receipt of screening mammography during the several years up to and including the date of the case’s diagnosis of breast cancer was ascertained from the records of the screening program.
Results
Receipt of a screening mammogram in the preceding 2 years was more common among controls (53 %) than cases (37 %), OR 0.51 (95 % CI 0.42–0.62). A decreased risk was observed among women in all age groups, including those 70–79 years (OR 0.40; 95 % CI 0.27–0.60).
Conclusion
Our findings suggest that receipt of screening mammography among women in Saskatchewan has been associated with a decreased risk of death from breast cancer.
Similar content being viewed by others
References
Humphrey LL, Helfand M, Chan BK et al (2002) Breast cancer screening: a summary of the evidence for the US preventive services task force. Ann Intern Med 137(5 Part 1):347–360
Chubak J, Rutter CM, Kamineni A et al (2013) Measurement in comparative effectiveness research. Am J Prev Med 44(5):513–519
Public Health Agency of Canada (2011) Organized breast cancer screening programs in Canada: report on program performance in 2005 and 2006. Health Canada, Ottawa
Edouard L, Eberts L, Baldwin J (1994) A population-based screening mammography program in Saskatchewan. Am J Public Health 84(6):1030–1031
Doyle GP, Major D, Chu C et al (2011) A review of screening mammography participation and utilization in Canada. Chronic Dis Inj Can 31(4):152–156
Canadian Task Force on Preventive Health, Tonelli C, Connor M, Gorber S et al (2011) Recommendations on screening for breast cancer in average-risk women aged 40–74 years. CMAJ 183(17):1991–2001
Nelson HD, Tyne K, Naik A et al (2009) Screening for breast cancer: an update for the US preventive services task force. Ann Intern Med 151(10):727–737 (W237–W242)
Downey W, Strang M, Beck P et al (2005) Health services databases in Saskatchewan. In: Strom B (ed) Pharmacoepidemiology, 4th edn. Wiley, Pennsylavania, pp 295–310
Pocobelli G, Newcomb PA, Li CI et al (2014) Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy. Breast Cancer Res Treat 145(2):439–447
Saskatchewan Cancer Agency. Screening program for breast cancer. http://www.saskcancer.ca/Default.aspx?DN=80e4bb14-ed7d-4f79-852f-3316d42de414
Woodman CB, Threlfall AG, Boggis CR et al (1995) Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme’s north western region. BMJ 310(6974):224–226
Weiss NS, McKnight B, Stevens NG (1992) Approaches to the analysis of case–control studies of the efficacy of screening for cancer. Am J Epidemiol 135(7):817–823
Cook NR, Rosner BA, Hankinson SE et al (2009) Mammographic screening and risk factors for breast cancer. Am J Epidemiol 170(11):1422–1432
Carney PA, O’Malley JP, Gough A et al (2013) Association between documented family history of cancer and screening for breast and colorectal cancer. Prev Med 57(5):679–684
Miller AB, To T, Baines CJ et al (2000) Canadian national breast screening study-2: 13-year results of a randomized trial in women aged 50–59 years. J Natl Cancer Inst 92(18):1490–1499
Brinkley D, Haybittle JL, Alderson MR (1984) Death certification in cancer of the breast. Br Med J (Clin Res Ed) 289(6443):465–467
Koepsell TD, Weiss NS (2003) Measurement error (Chapter 10). In: Epidemiologic methods: studying the occurrence of illness. Oxford University Press, New York, p 215–246
Nickson C, Mason KE, English DR et al (2012) Mammographic screening and breast cancer mortality: a case–control study and meta-analysis. Cancer Epidemiol Biomark Prev 21(9):1479–1488
Nickson C, Mason KE, English DR et al (2012) Screening and breast cancer mortality—response. Cancer Epidemiol Biomark Prev 21(12):2276–2277
Calle EE, Miracle-McMahill HL, Thun MJ et al (1994) Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 139(10):1001–1007
Petrelli JM, Calle EE, Rodriguez C et al (2002) Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 13(4):325–332
Miltenburg GA, Peeters PH, Fracheboud J et al (1998) Seventeen-year evaluation of breast cancer screening: the DOM project, the Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom. Br J Cancer 78(7):962–965
Fielder HM, Warwick J, Brook D et al (2004) A case–control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 11(4):194–198
Allgood PC, Warwick J, Warren RM et al (2008) A case–control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98(1):206–209
Puliti D, Miccinesi G, Collina N et al (2008) Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction. Br J Cancer 99(3):423–427
Roder D, Houssami N, Farshid G et al (2008) Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 108(3):409–416
van Schoor G, Moss SM, Otten JD et al (2011) Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 104(6):910–914
Otto SJ, Fracheboud J, Verbeek AL et al (2012) Mammography screening and risk of breast cancer death: a population-based case–control study. Cancer Epidemiol Biomark Prev 21(1):66–73
Palli D, Rosselli del Turco M, Buiatti E et al (1989) Time interval since last test in a breast cancer screening programme: a case–control study in Italy. J Epidemiol Community Health 43(3):241–248
Gabe R, Tryggvadottir L, Sigfusson BF et al (2007) A case–control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48(9):948–955
Acknowledgments
This study was funded by the National Cancer Institute at the National Institutes of Health grant R03CA135700 (PI: Noel S. Weiss). Noel S. Weiss is supported by an established investigator award in cancer prevention and control (K05CA092002) from the National Cancer Institute at the National Institutes of Health. Gaia Pocobelli is supported by training grant T32 HD052462 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. We thank Dr. MaryRose Stang of the Saskatchewan Ministry of Health for assistance with data acquisition and Barb Byrne Simon and Matthew Anderson of the University of Washington for administrative support. This study is based in part on de-identified data provided by the Saskatchewan Ministry of Health. The interpretation and conclusions contained herein do not necessarily represent those of the Government of Saskatchewan or the Saskatchewan Ministry of Health.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pocobelli, G., Weiss, N.S. Breast cancer mortality in relation to receipt of screening mammography: a case–control study in Saskatchewan, Canada. Cancer Causes Control 26, 231–237 (2015). https://doi.org/10.1007/s10552-014-0503-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-014-0503-2